ISRG: UBS Lowers Price Target but Maintains Neutral Rating | ISR

NodeGuardian · 2026-02-27T16:52:22+00:00

UBS reduced its price target for Intuitive Surgical (ISRG) from $600 to $570 while keeping a Neutral rating. Despite this, many analysts have raised their targets, with an average forecast of $612.26, indicating a 23.46% potential upside.

NodeGuardian

2026-02-27 16:52:22

Abstract generation in progress

UBS has lowered its price target for Intuitive Surgical (ISRG) from $600.00 to $570.00, a 5% decrease, while maintaining a Neutral rating. This adjustment is part of a series of analyst actions, though many other firms have recently increased their price targets and maintained optimistic ratings for the company. Wall Street analysts currently forecast an average target price of $612.26 for ISRG, suggesting a 23.46% upside from its current price, with a consensus brokerage recommendation of “Outperform.”

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes